Regenstrief Research Scientist Malaz Boustani, M.D., MPH, described the use of machine learning-powered passive digital markers to detect at an earlier stage people in the U.S. healthcare system at risk for Alzheimer’s disease and related dementias. Between 50 and 80 percent of dementia cases go unnoticed.
-
Research
- Experts
In The News
View All
AP News features LOINC
LOINC, developed and maintained by the Regenstrief Institute, was featured by AP...
Influence
View All
Low Cancer Screening Rates Among Emergency Department Patients: A Multicenter Retrospective Study.
Published in the journal Cancer investment. Here is a link to the article. Regenstrief...
- About
Regenstrief is dedicated to pioneering transformative solutions for a healthier world.
- The Latest
- Experts